Investigational drug · Phase 2
Vipoglanstat
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Endometriosis.
Phase 2Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "Vipoglanstat"
First trial start
2025
Oct 15, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Vipoglanstat", any sponsor or status.
Conditions studied
As listed on its trial records.
- Endometriosis
Approved drugs for the same conditions: Endometriosis · Endocrinology and women's health
Largest trials
Live from ClinicalTrials.gov: studies naming "Vipoglanstat" as an intervention, largest first.
- A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With EndometriosisPivotal-lookingActive, not recruiting
Gesynta Pharma ABIndustry
NCT07260669 · 213 participants · Start Oct 15, 2025 · Primary completion Jun 2027
Drug: Vipoglanstat; Placebo · For: Endometriosis
Sites: Blagoevgrad, Bulgaria; Sofia, Bulgaria; Brno, Czechia · 44 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Characterization of a new specific mPGES-1 inhibitor in cardiovascular system.
Lin X, Feng H, Zhang JR, et al. · Sci Rep 2025
- A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's.
Tornling G, Edenius C, Pauling JD, et al. · Rheumatology (Oxford) 2025
Also in development for Endometriosis
- Leuprorelin acetateLeuprolide Open Label, DKF-MA102Phase 33 trials
Pfizer · Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
- KLH-2109Phase 32 trials
JW Pharmaceutical · Menorrhagia, Uterine Fibroids, Endometriosis
- HMI-115Phase 31 trial
Hope Medicine (Nanjing) Co., Ltd · Endometriosis
- OG-6219Phase 21 trial
Organon and Co · Endometriosis
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.